The Influence of Postoperative Complications on Long-Term Prognosis in Patients with Colorectal Carcinomas (2020) Beck C, Schellerer V, Weber K, Brunner M, Agaimy A, Semrau S, Grützmann R, Merkel S Conference contribution A Randomized Phase IIa Trial with Temsirolimus versus Sunitinib in Advanced Non-Clear Cell Renal Cell Carcinoma: An Intergroup Study of the CESAR Central European Society for Anticancer Drug Research-EWIV and the Interdisciplinary Working Group on Renal Cell Cancer (IAGN) of the German Cancer Society (2020) Bergmann L, Grünwald V, Maute L, Grimm MO, Weikert S, Schleicher J, Klotz T, et al. Journal article Expression of the Immune Modulators of the PD-1: PD-L1 Axis in oral Leukoplakia (2020) Ries J, Wehrhan F, Baran C, Agaimy A, Danzer E, Bolzel S, Büttner-Herold M, et al. Conference contribution Zoledronate Shifts Macrophage Polarization towards M1 in Vivo - An Animal Study on Wistar Rats (2020) Weber M, Amann KU, Homm A, Müller S, Ries J, Geppert CI, Preidl R, et al. Conference contribution Specific inhibition of PRMT5 suppresses human CD8+T cells by upregulation of p53 and impairment of the AKT pathway similar to the tumor metabolite MTA (2019) Strobl C, Schaffer S, Völkl S, Haug T, Peter K, Böttcher M, Mougiakakos D, et al. Conference contribution, Abstract of a poster Patient Attitude towards Videodermatoscopy for the Detection of Skin Cancer: A Cross-Sectional Study. (2019) Steeb T, Wessely A, Niesert AC, Ruzicka T, Von Braunmuehl T, Berking C, Heppt MV Journal article Pet positivity after 2 cycles of abvd is a risk factor in patients with early-stage favorable Hodgkin lymphoma treated in the phase 3 GHSG HD16 study (2019) Fuchs M, Goergen H, Kobe C, Kuhnert G, Hitz F, Greil R, Sasse S, et al. Conference contribution Baseline Results of the German Health Services Research Study PROSa - quality of care and patient reported outcomes (2019) Eichler M, Richter S, Hohenberger P, Kasper B, Andreou D, Pink D, Golcher H, et al. Conference contribution BRAF inhibitor treatment in hairy cell leukemia: a long-term follow up study (2019) Liebers N, Roider T, Bohn JP, Pircher A, Ferstl B, Ebnoether M, Perker M, et al. Conference contribution Comparison of leukemia-associated immunophenotype (LAIP)-based and different-from-normal (DfN)-based analysis of measurable residual disease (MRD) in patients with AML (2019) Von Bonin M, Buecklein V, Krause S, Voelkl S, Rieger M, Berg T, Brendel C, et al. Conference contribution